Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
新型减毒活疫苗（1型和3型口服脊髓灰质炎疫苗）在美国健康成人中的安全性和免疫原性：一项首次人体试验、观察者设盲、多中心、1期随机对照试验
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(25)00285-3
Mercer, Laina D; Seña, Arlene C; Colgate, E Ross; Crothers, Jessica W; Wright, Peter F; Al-Ibrahim, Mohamed; Tritama, Erman; Vincent, Annelet; Mainou, Bernardo A; Zhang, Yiting; Konopka-Anstadt, Jennifer; Bandyopadhyay, Ananda S; Fix, Alan; Konz, John O; Gast, Chris
